P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 143 STUDY. (23rd June 2022)

• Record Type: Journal Article
• Authors: Groen, K.; Seefat, M.; Nasserinejad, K.; Stege, C. A.; van der Spek, E.; Bilgin, Y. M.; Kentos, A.; Sohne, M.; van Kampen, R. J.; Ludwig, I.; Thielen, N.; Durdu-Rayman, N.; de Graauw, N. C.; van de Donk, N. W.; de Waal, E. G.; Vekemans, M.-C.; Timmers, G. J.; van der Klift, M.; Soechit, S.; Geerts, P. A.; Silbermann, M. H.; Oosterveld, M.; Nijhof, I.; Sonneveld, P.; Klein, S. K.; Levin, M.-D.; Zweegman, S.
• Is Part Of: HemaSphere. Volume 6(2022)Supplement 3
• Page Start: 797
• Page End: 798
• Publication Date: 2022-06-23
• Subjects: Hematology -- Periodicals; 616.15005
• DOI: 10.1097/01.HS9.0000846496.51905.dd
• Languages: English
• ISSNs: 2572-9241